Reuters logo
BRIEF-VIKING THERAPEUTICS ANNOUNCES PURCHASE AGREEMENTS FOR UP TO $16.25 MILLION WITH LINCOLN PARK CAPITAL
September 29, 2017 / 11:08 AM / 23 days ago

BRIEF-VIKING THERAPEUTICS ANNOUNCES PURCHASE AGREEMENTS FOR UP TO $16.25 MILLION WITH LINCOLN PARK CAPITAL

Sept 29 (Reuters) - Viking Therapeutics Inc:

* VIKING THERAPEUTICS ANNOUNCES PURCHASE AGREEMENTS FOR UP TO $16.25 MILLION WITH LINCOLN PARK CAPITAL

* VIKING THERAPEUTICS INC - ‍ANNOUNCED IT HAS ENTERED INTO A $15.0 MILLION COMMON STOCK PURCHASE AGREEMENT WITH LINCOLN PARK CAPITAL FUND LLC​

* VIKING THERAPEUTICS INC - CONTINUE TO ANTICIPATE TOP LINE RESULTS FROM PHASE 2 TRIAL OF VK5211 IN HIP FRACTURE IN Q4 OF 2017

* VIKING THERAPEUTICS - CO WILL HAVE RIGHT AND SOLE DISCRETION TO SELL TO LPC UP TO $15 MILLION IN SHARES OF COMMON STOCK OVER 30-MONTH PERIOD CONTINGENT

* VIKING THERAPEUTICS - ‍UNDER SEPARATE PURCHASE AGREEMENT, LINCOLN PARK CAPITAL FUND AGREED TO BUY $1.25 MILLION OF CO‘S STOCK AT $1.78 PER SHARE​

* VIKING THERAPEUTICS - ‍UNDER TERMS OF COMMON STOCK PURCHASE AGREEMENT, CO TO CONTROL TIMING, AMOUNT OF ANY FUTURE SALE OF SHARES OF COMMON STOCK TO LPC​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below